Paige AI's FDA-cleared prostate cancer detection system was deployed in 50+ major cancer centers in 2025, analyzing whole-slide pathology images to identify cancerous cells with 97.8% sensitivity β significantly higher than human pathologists alone. Its Paige Prostate and Paige Breast tools processed 1 million pathology slides in 2024, with studies showing AI assistance reduced both false positive and false negative rates for oncologists.

Comments on "AI-Powered Pathology (Paige AI)"
Create a free account or sign in to join the discussion.
Sign in to join the conversation